Schonfeld Strategic Advisors’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.55M Buy
90,846
+41,143
+83% +$704K 0.01% 1028
2025
Q1
$3.17M Buy
49,703
+293
+0.6% +$18.7K 0.02% 623
2024
Q4
$6.01M Sell
49,410
-11,952
-19% -$1.45M 0.03% 406
2024
Q3
$7.66M Buy
61,362
+46,647
+317% +$5.83M 0.05% 311
2024
Q2
$2.32M Buy
+14,715
New +$2.32M 0.02% 737
2024
Q1
Sell
-31,618
Closed -$3.05M 2177
2023
Q4
$3.05M Sell
31,618
-59,107
-65% -$5.7M 0.02% 606
2023
Q3
$11M Buy
90,725
+753
+0.8% +$91.3K 0.09% 289
2023
Q2
$10.3M Buy
89,972
+77,809
+640% +$8.91M 0.09% 330
2023
Q1
$1.68M Sell
12,163
-133,628
-92% -$18.4M 0.02% 743
2022
Q4
$18.9M Buy
145,791
+75,175
+106% +$9.74M 0.16% 179
2022
Q3
$7.81M Sell
70,616
-1,986
-3% -$220K 0.07% 388
2022
Q2
$5.44M Buy
72,602
+38,937
+116% +$2.92M 0.05% 410
2022
Q1
$2.63M Sell
33,665
-7,035
-17% -$549K 0.02% 594
2021
Q4
$3.67M Buy
+40,700
New +$3.67M 0.03% 495
2021
Q3
Sell
-3,283
Closed -$255K 2287
2021
Q2
$255K Sell
3,283
-6,518
-67% -$506K ﹤0.01% 1503
2021
Q1
$731K Buy
9,801
+5,992
+157% +$447K 0.01% 971
2020
Q4
$649K Sell
3,809
-2,691
-41% -$459K 0.01% 919
2020
Q3
$913K Buy
+6,500
New +$913K 0.02% 687
2020
Q1
Sell
-4,540
Closed -$586K 1489
2019
Q4
$586K Sell
4,540
-98,160
-96% -$12.7M 0.01% 687
2019
Q3
$7.74M Sell
102,700
-17,000
-14% -$1.28M 0.23% 119
2019
Q2
$18.2M Buy
+119,700
New +$18.2M 0.64% 26
2018
Q4
Sell
-68,800
Closed -$11.1M 1217
2018
Q3
$11.1M Sell
68,800
-28,300
-29% -$4.57M 0.49% 35
2018
Q2
$12.8M Buy
97,100
+88,438
+1,021% +$11.7M 0.7% 9
2018
Q1
$641K Sell
8,662
-81,338
-90% -$6.02M 0.05% 420
2017
Q4
$5.01M Sell
90,000
-109,789
-55% -$6.11M 0.41% 70
2017
Q3
$9.06M Buy
+199,789
New +$9.06M 0.83% 14
2017
Q2
Sell
-11,972
Closed -$355K 747
2017
Q1
$355K Buy
11,972
+1,872
+19% +$55.5K 0.04% 437
2016
Q4
$277K Sell
10,100
-43,938
-81% -$1.21M 0.04% 437
2016
Q3
$3.32M Buy
54,038
+18,921
+54% +$1.16M 0.56% 41
2016
Q2
$670K Buy
+35,117
New +$670K 0.15% 186